The Myelodysplastic Syndromes Channel on VJHemOnc is an independent medical education platform, supported with funding from Geron (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
ASH 2024 | Looking forward to the VJHemOnc post-ASH MDS highlights webinar
Amer Zeidan, MBBS, MHS, Yale University and Yale Cancer Center, New Haven, CT, discusses the upcoming post-ASH webinar hosted by VJHemOnc that will cover the highlights in myelodysplastic syndromes (MDS). This interview took place at the 66th ASH Annual Meeting and Exposition, held in San Diego, CA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Transcript (AI-generated)
We are very excited about our upcoming webinar focusing on the highlights in myelodysplastic syndromes. This VJHemOnc seminar is going to focus on the most promising abstracts from the meeting. So we have actually a number of the faculty who presented at the meeting who will be joining us to do these presentations and then they will be present for a discussion and a Q&A. I think this is going to be a very nice condensed material that summarizes all the new changes in MDS...
We are very excited about our upcoming webinar focusing on the highlights in myelodysplastic syndromes. This VJHemOnc seminar is going to focus on the most promising abstracts from the meeting. So we have actually a number of the faculty who presented at the meeting who will be joining us to do these presentations and then they will be present for a discussion and a Q&A. I think this is going to be a very nice condensed material that summarizes all the new changes in MDS. So I look forward to everybody joining us for that.
This transcript is AI-generated. While we strive for accuracy, please verify this copy with the video.
Read more...
